Mariana Oncology
Brian King, CPA, currently serves as the Executive Director, Controller at Mariana Oncology since February 2024. Previously, Brian held the position of Corporate Controller at Xilio Therapeutics, Inc. from May 2020 to February 2024. Prior roles include Interim Controller and various leadership positions in consolidations and international accounting at TESARO, Inc. from February 2017 to May 2020, as well as Senior Manager at The Siegfried Group, providing interim financial assistance to Fortune 1000 companies. Other experiences include Financial Reporting Manager at Iron Mountain, Consultant at CenturyLink, Senior Accountant at Boston Medical Center, and Senior Auditor at Ernst & Young. Brian earned a Master of Science in Accounting (MSA) and a Bachelor of Business Administration (BBA) in Accounting from the Isenberg School of Management at UMass Amherst.
Mariana Oncology
1 followers
Mariana Oncology is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Their mission at Mariana is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.